Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCRX | DYN | ELVN | ||
| Company | Biocryst Pharma Inc | Dyne Therapeutics Inc | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.28 | 17.22 | 38.29 | ||
| High | 9.52 | 17.46 | 39.22 | ||
| Low | 9.17 | 16.87 | 35.60 | ||
| Latest | 9.40 | 17.04 | 36.17 | ||
| Change | +0.07 | -0.10 | -2.66 | ||
| % Change | +0.75% | -0.58% | -6.85% | ||
| Volume | 1,306,454 | 713,202 | 1,450,264 | ||
| 20-Day Average Volume | 6,843,083 | 2,665,341 | 1,521,825 | ||
| Previous Close | 9.33 | 17.14 | 38.83 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.05 | 17.56 | 30.88 | ||
| 20-Day Raw Stochastic | 59.22% | 46.98% | 65.37% | ||
| 20-Day Relative Strength | 62.61 | 48.29 | 63.54 | ||
| Weighted Alpha | +39.27 | +63.18 | +34.21 | ||
| Today's Opinion | 72% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | Hold | 24% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.72% since 03/23/26 | -4.59% since 03/23/26 | +16.20% since 03/23/26 | ||
| Low | 8.89 on 03/26/26 | 16.87 on 03/30/26 | 29.37 on 03/24/26 | ||
| High | 10.13 on 03/24/26 | 19.29 on 03/26/26 | 40.62 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +7.83% since 02/27/26 | +9.15% since 02/27/26 | +20.58% since 02/27/26 | ||
| Low | 8.15 on 03/13/26 | 14.00 on 03/02/26 | 26.70 on 03/18/26 | ||
| High | 10.32 on 03/20/26 | 20.03 on 03/10/26 | 40.62 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +23.66% since 12/26/25 | -14.92% since 12/26/25 | +119.63% since 12/26/25 | ||
| Low | 6.23 on 02/05/26 | 14.00 on 03/02/26 | 14.78 on 01/06/26 | ||
| High | 10.32 on 03/20/26 | 20.17 on 12/29/25 | 40.62 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | +23.66% since 09/26/25 | +29.66% since 09/26/25 | +78.91% since 09/26/25 | ||
| Low | 6.00 on 10/14/25 | 11.92 on 09/29/25 | 14.78 on 01/06/26 | ||
| High | 10.32 on 03/20/26 | 25.00 on 10/28/25 | 40.62 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,339,973 | 2,828,563 | 2,322,034 | ||
| Shares Outstanding, K | 250,801 | 165,027 | 59,800 | ||
| Annual Sales | 874,840,000 | 0 | 0 | ||
| Annual Net Income | 263,860,000 | -446,210,000 | -103,690,000 | ||
| Last Quarter Sales | 406,560,000 | 0 | 0 | ||
| Last Quarter Net Income | 245,850,000 | -111,960,000 | -29,670,000 | ||
| 60-Month Beta | 0.74 | 1.34 | 0.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.12 on 02/26/26 | -0.76 on 03/02/26 | -0.48 on 03/03/26 | ||
| Latest Earnings Date | 05/04/26 | 05/14/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 7.19 | 0.00 | 0.00 | ||